Toronto Region Research Alliance

Why do health care companies choose Toronto Region for their commercial operations? Chemist Edward B. Shuttleworth established Canada’s first major pharmaceutical operation in Toronto in 1879. From these early beginnings, the Toronto Region is now one of the largest pharmaceutical and biotechnology clusters in North America. Twenty-five of the top 50 global pharmaceutical companies have Canadian headquarters in the Toronto Region.

Written byToronto Region Research Alliance
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Chemist Edward B. Shuttleworth established Canada’s first major pharmaceutical operation in Toronto in 1879. From these early beginnings, the Toronto Region is now one of the largest pharmaceutical and biotechnology clusters in North America. Twenty-five of the top 50 global pharmaceutical companies have Canadian headquarters in the Toronto Region. Dozens of medium and small companies are located in the region.

Why choose the Toronto Region? The reason is simple – the specialized expertise and services to run commercial operations are right here.

In addition to an experienced workforce of close to 40,000 people, there are more than 170 companies that provide specialized services for the health care, pharmaceutical and biotechnology sectors. All the essential functions are here: research, clinical, manufacturing, sales and sales operations, marketing and market research, supply chain management, regulatory, and market access.

Contract research Sixty contract or clinical research organizations (CROs) are located in the Toronto Region. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of small blue creatures called Nergals. Some have hearts above their heads, which signify friendship. There is one Nergal who is sneezing and losing health, which is denoted by minus one signs floating around it.
June 2025, Issue 1

Nergal Networks: Where Friendship Meets Infection

A citizen science game explores how social choices and networks can influence how an illness moves through a population.

View this Issue
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Unraveling Complex Biology with Advanced Multiomics Technology

Unraveling Complex Biology with Five-Dimensional Multiomics

Element Bioscience Logo
Resurrecting Plant Defense Mechanisms to Avoid Crop Pathogens

Resurrecting Plant Defense Mechanisms to Avoid Crop Pathogens

Twist Bio 
The Scientist Placeholder Image

Seeing and Sorting with Confidence

BD

Products

The Scientist Placeholder Image

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity 

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series

agilent-logo

Agilent Announces the Enhanced 8850 Gas Chromatograph

parse-biosciences-logo

Pioneering Cancer Plasticity Atlas will help Predict Response to Cancer Therapies